News | Venous Therapies | October 31, 2019

IVUS Better Than Venography to Identify Venous Stent Landing Zones

Comparison between intravascular ultrasound and angiography in iliac vein stenting 

A comparison of intravascular ultrasound (IVUS) vs. angiography found a significant mismatch and showed the benefits of IVUS in venous interventions.

A comparison of intravascular ultrasound (IVUS) vs. angiography found a significant mismatch and showed the benefits of IVUS in venous interventions.


October 31, 2019 – In a large series of iliac vein stent cases, a blinded comparison found intravascular ultrasound (IVUS) superior to venography in determining the proper location of treatment zones. This is reported in the November 2019 edition of the Journal of Vascular Surgery: Venous and Lymphatic Disorders.[1] 

Researchers from The RANE Center, St. Dominic’s Memorial Hospital, Jackson, Miss., performed a retrospective, single-center cohort study of 155 limbs treated for chronic iliac vein occlusion between 2013 and 2015.

“Adequate assessment of the location and degree of stenosis and delineation of venous anatomy for optimal landing zones are key elements in the success of interventions to treat chronic obstructions of the deep venous system,” noted lead author Myriam Montminy, M.D., MSc, FRCSC.

“While venography is more accessible and less expensive to perform than IVUS, an increasing number of studies demonstrate that IVUS is significantly more sensitive than venography in identifying stenotic lesions in the iliac-caval segments,” Montminy explained. “Our study aimed to take this one step further by comparing these modalities in identifying the key parameters required to guide stent placement.”

Key demographics of this series included:

   • Age, years, mean (SD) - 59 (13)
   • Male -30%
   • Left leg - 61%
   • Post-thrombotic - 72%
   • Non-thrombotic - 28%

In the study, led by senior investigator Seshadri Raju, M.D., FACS, all of the cases utilized both venography and IVUS.  Comparisons between the modalities were made in a blinded fashion.

With regards to evaluation of the main venous stenosis, venography (compared with IVUS):

   • Failed to identify the stenosis in 19% of cases
   • Underestimated the degree of stenosis
   • Failed to locate accurately the stenosis in 68% of cases
 
Further, in identifying the location of the iliac-caval confluence (the proximal landing zone), venography correlated with IVUS in 15% of cases, wherein IVUS revealed the confluence to be higher in 74% of cases (mean of one vertebral height higher).

Lastly, with regards to the distal landing zone, venography correlated with IVUS in 26% of cases, wherein IVUS located the optimal site lower in 64% of cases.

“This study highlights that venography compared to IVUS is likely to be deficient in all three areas of concern in venous stenting cases – location of the maximal stenosis as well as the optimal proximal and distal landing zones,” Montminy added.

Venography is still a desirable adjunct in iliac vein stenting as it provides a panoramic view of the pathologic process, including collaterals, she said. “Additionally, IVUS may miss or provide only a partial image of certain lesions situated at the hypogastric-iliac and iliac-caval confluences due to the absence of a centering mechanism.”

While it is currently unknown if the superiority of IVUS in identifying key parameters essential for iliac vein stenting translates into improved clinical outcomes, the results of this study further defines the complementary roles venography and IVUS play in this growing area of vascular intervention.

This research article is open source and free to the public until Dec. 31 at vsweb.org/JVSVL-IVUS.

Reference:

1. Myriam L. Montminy, James D. Thomasson, Guillermo J. Tanaka, et al. A comparison between intravascular ultrasound and venography in identifying key parameters essential for iliac vein stenting. Journal of Vascular Surgery: Venous and Lymphatic Disorders. November 2019,  Volume 7, Issue 6, Pages 801–807. 
DOI: https://doi.org/10.1016/j.jvsv.2019.03.015. 


Related Content

News | Venous Therapies

October 14, 2022 — Medtronic, a global leader in medical technology, announced the 36-month final results from the ABRE ...

Home October 14, 2022
Home
News | Venous Therapies

November 22, 2021 — Fewer than 10 days of low-molecular-weight heparin (LMWH) after stenting for extensive iliofemoral ...

Home November 22, 2021
Home
News | Venous Therapies

February 22, 2021 — The U.S. Food and Drug Administration (FDA) recently cleared the Cook Medical Zilver Vena Venous ...

Home February 22, 2021
Home
News | Venous Therapies

October 26, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic Abre venous self-expanding ...

Home October 26, 2020
Home
Technology | Venous Therapies

May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System for ...

Home May 06, 2019
Home
Technology | Venous Therapies

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...

Home April 03, 2019
Home
News | Venous Therapies

August 8, 2018 — Boston Scientific Corp. announced it has signed an agreement to acquire Veniti Inc., which has ...

Home August 08, 2018
Home
Feature | Venous Therapies | Tif Siragusa, M.D.

The introduction of thermal ablation revolutionized the treatment of varicose veins, yet recurrence remains a stubborn ...

Home April 30, 2018
Home
News | Venous Therapies

January 26, 2018 – Medtronic plc announced the initiation of its investigational device exemption (IDE) study for the ...

Home January 26, 2018
Home
News | Venous Therapies

September 11, 2017 — Veniti Inc. announced that Boston Scientific will distribute the Vici Venous Stent under a limited ...

Home September 11, 2017
Home
Subscribe Now